CME Support Proposal
This certified CME activity is designed for anterior segment specialists and general ophthalmologists involved in the management of ocular disorders and diseases.
Presentations will consist of lectures and panel discussions, featuring question-and-answer sessions and actual case presentations.
Ophthalmologists face increasing pressure to remain current in their clinical knowledge, diagnostic skills and treatment selection due to shifting demographics and increasing numbers of aging patients.
These changes are of particular significance in the areas of refractive surgery, cataract surgical services, cornea services, and glaucoma management. As population trends lead to changes in ocular disease prevalence, ophthalmic development in pharmaceuticals and new medical device technology continues to change the treatment strategies available to clinicians and surgeons. Practice patterns are shifting as well, with practice management embracing the need for integrated management.
In the past 5 years alone, ophthalmology has seen the introduction of femtosecond lasers for cataract surgery, intraoperative aberrometry, enhanced depth of focus intraocular lenses, new IOL calculators, presbyopia-correcting IOLs and corneal inlays, micro-incisional glaucoma surgery (MIGS) and the devices associated with them, a bevy of diagnostic tools to better identify and quantify dry eye, the second dry eye pharmacologic treatment, software improvements on refractive lasers, small incision lenticule extraction (SMILE), and the U.S. approval of collagen corneal crosslinking (CXL).
Ongoing education about these innovations is necessary to provide eye care professionals with the best means to enhance patient outcomes
Upon completion of this activity, the participants should be able to:
- Evaluate the latest published literature and meta-analyses to differentiate the benefits/detractors of femtosecond laser for cataract surgery compared to traditional phacoemulsification
- Assess the ability of topical ophthalmic NSAIDs to treat postop inflammation and pain in a cataract patient
- Discuss how to ensure maximum efficacy with toric lenses
- Discuss how to manage visually significant astigmatism
- Evaluate the current and potential future therapies for dry eye disease
- Evaluate the safety and efficacy of different treatment modalities for ocular hypertension and primary open-angle glaucoma
- Discuss future developments and direction of therapeutics and surgical devices for managing glaucoma
- Formulate strategies to manage patients with presbyopia in an integrated care system
- Develop a strategy to improve integrated patient management
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC, the American College of Eye Surgeons (ACES), the American Board of Eye Surgery (ABES) and the Society for Excellence in Eyecare (SEE). Evolve Medical Education LLC is accredited by the ACCME to provide continuing medical education for physicians.
Evolve Medical Education, LLC this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In compliance with ACCME standards for commercial support and Evolve Medical Education LLC’s policy and procedure for resolving conflicts of interest, this live activity will be peer reviewed for clinical content validity to ensure the activity’s materials are fair, balanced, and free of bias; the activity materials represent a standard of practice within the medical profession; and any studies cited in the materials upon which recommendations are based are scientifically objective and conform to research principles generally accepted by the scientific community.
In accordance with the disclosure policies of Evolve Medical Education LLC and to conform with ACCME and US Food and Drug Administration guidelines, anyone in a position to affect the content of a CME activity is required to disclose to the activity participants: (1) the existence of any financial interest or other relationships with the manufacturers of any commercial products/devices or providers of commercial services; and (2) identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.